QR kód

Assessing the intracranial metabolic score as a novel prognostic tool in primary CNS lymphoma with end of induction-chemotherapy 18F-FDG PET/CT and PET/MR

Abstract Background The metabolic response of primary central nervous system lymphoma (PCNSL) patients has yet to be evaluated. This study aimed to assess the prognostic value of a novel scoring scale, the intracranial metabolic score (IMS), in PCNSL patients receiving end-of-therapy 18F-FDG PET/CT...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Yiwen Mo, Yongjiang Li, Yuqian Huang, Mingshi Chen, Chao Zhou, Xinling Li, Yuan Wei, Ruping Li, Wei Fan, Xu Zhang
Médium: Artigo
Jazyk:Inglês
Vydáno: BMC 2024-11-01
Edice:Cancer Imaging
Témata:
On-line přístup:https://doi.org/10.1186/s40644-024-00798-1
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!